Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The role of prolyl hydroxylase domain protein 2 (PHD2) in carcinogenesis has been studied in a variety of cancer types. However, the association between PHD2 and human hepatocellular carcinoma (HCC) has not been documented. A total of 220 patients with primary HCC who underwent a curative liver resection were enrolled in this study. The tumor samples were obtained during the surgical procedure from each patient for PHD2 immunohistological staining. All the patients were followed up and the disease-free survival (DFS) and overall survival (OS) were evaluated. We found that that high PHD2 expression was significantly associated with higher stage (stages III + IV) (odds ratio [OR] = 5.576, P < 0.001), larger tumor size (> 5 cm) (OR = 6.176, P < 0.001), poorer tumor differentiation (OR = 1.424, P = 0.003), and higher serum alpha fetoprotein (AFP) level (OR = 6.861, P < 0.001). Compared to those with high PHD2 expressions, patients with low PHD2 expression had significantly longer DFS and OS periods (both P < 0.001). Cox regression analyses revealed that higher levels of PHD2, tumor size, tumor stage, as well as serum AFP level were predictors for a worse prognosis in patients with HCC. PHD2 expression in the tumors is associated with the clinical features and prognosis of patients with HCC; it may be used as a histological marker for HCC.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602600 | PMC |
| http://dx.doi.org/10.1097/MD.0000000000000179 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Targeting HDAC8 sensitizes tyrosine kinase inhibitors in the elimination of B-cell acute lymphoblastic leukemia cells through degradation of HIF-1α.
Leukemia
September 2025
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.
Tyrosine kinase inhibitors (TKIs) only partially inhibit the growth of Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia (Ph B-ALL) cells, and often lead to rapid relapse. Therefore, it is essential to elucidate the mechanisms of resistance and develop novel treatment strategies. Histone deacetylases (HDACs) are often dysregulated in hematological malignancies, and many HDAC inhibitors have shown potent antitumor activities.
View Article and Find Full Text PDFHypoxia-inducible factor-2 stabilization is not sufficient to induce erythropoietin production in deeper medullary fibroblasts.
J Physiol
August 2025
Physiology I; Institute of Physiology, University of Regensburg, Regensburg, Germany.
Under hypoxaemic conditions, cortical fibroblasts primarily produce erythropoietin (EPO). However, we have previously shown that most interstitial fibroblasts positive for platelet-derived growth factor receptor β (PDGFR-β) in all kidney zones are also able to produce EPO. Therefore, we wondered if either the physiological stimuli might not be sufficient to stabilize the hypoxia-inducible factor (HIF)-2 in medullary fibroblasts or if different expression patterns or functions of the HIF-regulating prolyl-4-hydroxylases (PHD) 2 and 3 might explain the restrictive EPO cell recruitment.
View Article and Find Full Text PDFNeuroprotective effects of Rosavin via HIF-1α signaling in a rat model of ischemic stroke.
Phytomedicine
September 2025
College of Pharmacology, Fujian University of Traditional Chinese Medicine, No.1, Qiu Yang Road, Min Hou Shang Jie, Fuzhou, 350122, China. Electronic address:
Background: Ischemic stroke is a common cerebrovascular disease and a major global cause of permanent disability and death. Angiogenesis plays a critical role in neurological recovery during cerebral ischemia. Rosavin is the main active ingredient of Rhodiola rosea for ischemic stroke treatment.
View Article and Find Full Text PDFTargeting HIF-P4H-2 in APP/PS1 Alzheimer's mouse model improves glucose metabolism, reduces dystrophic neuritis, and maintains exploratory activity.
J Biol Chem
August 2025
Biocenter Oulu, Research Unit of Extracellular Matrix and Hypoxia, Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland. Electronic address:
Alzheimer's disease is the most common cause of dementia with limited treatment options. We asked whether activation of the hypoxia-inducible factor (HIF) pathway via genetic deficiency of HIF prolyl 4-hydoxylase-2 (HIF-P4H-2; also known as PHD2/EGLN1) could be an Alzheimer's disease-modifying therapy using transgenic amyloid precursor protein (APP)/presenilin 1 (PS1) female mice. At 12 months of age, APP/PS1/Hif-p4h-2 mice had 20% less cortical amyloid-β (Aβ) and less dystrophic neurites around amyloid plaques compared with APP/PS1 mice used as controls.
View Article and Find Full Text PDFTibetan PHD2D4E;C127S variant protects from viral diseases in hypoxia, but predispose to infections in normoxia via HIFα:IFN axis.
PLoS Pathog
June 2025
Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, India.
We previously reported that Tibetan-specific variant of prolyl-hydroxylase-2 (PHD2)D4E;C127S protects highlanders from hypoxia-triggered pathologies by destabilizing hypoxia-inducible factor (HIF)-1α. Others have reported that stabilized HIF1α negatively regulates interferon (IFN)-regulating factor (IRF)-3 under hypoxia. We examined the role of PHD2D4E;C127S variant in IFN synthesis in immune cells during viral infections.
View Article and Find Full Text PDF